Effects of intranasally-delivered pro-nerve growth factors on the septo-hippocampal system in healthy and diabetic rats.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 01 04 2020
revised: 22 06 2020
accepted: 25 06 2020
pubmed: 19 7 2020
medline: 14 8 2021
entrez: 19 7 2020
Statut: ppublish

Résumé

Pro-nerve growth factor (proNGF) is the predominant form of NGF in the brain and its levels increase in neurodegenerative diseases. The balance between NGF receptors may explain the contradictory biological activities of proNGF. However, the specific role of the two main proNGF variants is mostly unexplored. proNGF-A is prevalently expressed in healthy brain, while proNGF-B content increases in the neuro-degenerating brain. Recently we have investigated in vitro the biological action of native mouse proNGF variants. To gain further insights into the specific functions of the two proNGFs, here we intranasally delivered mouse-derived proNGF-A and proNGF-B to the brain parenchyma of healthy and diabetic rats, the latter characterized by dysfunction in spatial learning and memory, in the septo-hippocampal circuitry and by relative increase in proNGF-B hippocampal levels. Exogenous proNGF-B induces depression of hippocampal DG-LTP and impairment of hippocampal neurogenesis in healthy animals, with concomitant decrease in basal forebrain cholinergic neurons and cholinergic fibers projecting to the hippocampus. proNGF-A, while ineffective in healthy animals, rescues the diabetes-induced impairment in DG-LTP and hippocampal neurogenesis, promoting the concomitant recovery of the basal forebrain cholinergic phenotype. Our experimental evidences suggest that the balance between different proNGFs may influence the development and progression of neurodegenerative diseases.

Identifiants

pubmed: 32681844
pii: S0028-3908(20)30291-4
doi: 10.1016/j.neuropharm.2020.108223
pii:
doi:

Substances chimiques

Protein Precursors 0
pro-nerve growth factor, mouse 0
Nerve Growth Factor 9061-61-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108223

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Marzia Soligo (M)

Institute of Translational Pharmacology, Consiglio Nazionale Delle Ricerche (CNR), Rome, Italy.

Virginia Protto (V)

Institute of Translational Pharmacology, Consiglio Nazionale Delle Ricerche (CNR), Rome, Italy.

Antonio Chiaretti (A)

Institute of Pediatrics, Università Cattolica del Sacro Cuore, Rome, Italy.

Sonia Piccinin (S)

European Brain Research Institute (EBRI), Rome, Italy.

Maria Egle De Stefano (ME)

Department of Biology and Biotechnology "Charles Darwin", Sapienza University, Rome, Italy.

Robert Nisticò (R)

European Brain Research Institute (EBRI), Rome, Italy; Department of Biology, University of Rome Tor Vergata, Rome, Italy.

Luisa Bracci-Laudiero (L)

Institute of Translational Pharmacology, Consiglio Nazionale Delle Ricerche (CNR), Rome, Italy; Division of Rheumatology and Immuno-Rheumatology Research Laboratories, Bambino Gesù Children's Hospital, Rome, Italy.

Luigi Manni (L)

Institute of Translational Pharmacology, Consiglio Nazionale Delle Ricerche (CNR), Rome, Italy. Electronic address: luigi.manni@ift.cnr.it.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH